Alessia Savio

Alessia Savio

Auto-generated profile, based on publicly available information

Alessia Savio

Department of Biology, University of Padua, Via Ugo Bassi 58/B, 35131 Padova, Italy

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
SFSofia De Felice
Sofia De Felice
CBChristian Buratto
Christian Buratto
ASAlessia Savio
Alessia Savio
MMMaria Morbidelli
Maria Morbidelli
Emanuele PapiniEmanuele Papini
Emanuele Papini
LCLaura Cendron
Laura Cendron
Human serum albumin (hSA) is the most abundant protein in human plasma, and its pharmacological properties, such as long plasma half-life mediated by the neonatal Fc receptor (FcRn) and its ability to bind endogenous and exogenous molecules, make it attractive for biotechnological applications. Currently, most wild type (WT) SAs are derived from human or bovine serum or produced in yeast and mammalian cells. Although well established, these methods are costly, difficult to reproduce, and not environmentally sustainable. Building on a previous study to design highly mutated hSA sequences, we extend the validation through an in-depth analysis of three engineered hSA variants; hSA1, hSA2, and hSA3, containing 16, 25, or 73 amino acid substitutions, respectively. These variants were designed for enhanced solubility, stability, and expression in Escherichia coli. All three variants showed low- micromolar affinities for hFcRn at pH 5.5, and negligible binding at pH 7.4. In a human endothelial cell-based recycling assay (HERA), the engineered hSA variants were recycled by hFcRn to the same extent as hSA isolated from serum. Exploring the properties of canonical drug-binding sites, warfarin affinity was comparable to WT hSA, whereas ibuprofen binding differed. Complementary cytotoxicity assays on human macrophages confirmed negligible toxicity and biocompatibility. A cryo-electron microscopy structure of hSA3 revealed that, despite extensive engineering, the native heart-shape of hSA, folding of domains, and its open conformation were preserved. These findings validate the structural integrity and functional adaptability of engineered hSA variants, underscoring their potential as versatile, animal-free solutions for next-generation therapeutics and biotechnological applications.

28 October 2026 in Protein Science
Verified
Journal Article
Closed access
PDF file
SFSofia De Felice
Sofia De Felice
CBChristian Buratto
Christian Buratto
ASAlessia Savio
Alessia Savio
MMMaria Morbidelli
Maria Morbidelli
EPEmanuele Papini
Emanuele Papini
LCLaura Cendron
Laura Cendron